financetom
Business
financetom
/
Business
/
India's Hindalco beats Q2 profit view on higher aluminium prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India's Hindalco beats Q2 profit view on higher aluminium prices
Nov 11, 2024 6:18 AM

Nov 11 (Reuters) - India's Hindalco Industries

, one of the country's largest aluminium and copper

producers, posted a higher-than-expected second-quarter profit

on Monday, helped by higher aluminium prices.

The company, owned by the Aditya Birla Group, said its

consolidated net profit jumped 78% to 39.09 billion rupees

($463.3 million) for the three months ended Sept. 30, beating

estimates.

Analysts, on average, had expected a profit of 34.46 billion

rupees, according to data compiled by LSEG.

($1 = 84.3700 Indian rupees)

(Reporting by Anuran Sadhu in Bengaluru; Editing by Sumana

Nandy and Abinaya Vijayaraghavan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gemfields sells Fabergé eggs maker for $50 million
Gemfields sells Fabergé eggs maker for $50 million
Aug 11, 2025
Aug 11 (Reuters) - Gemstones miner Gemfields Group said on Monday it sold its entire interest in Fabergé Limited, the maker of the jewelled Fabergé eggs, to SMG Capital for $50 million, concluding a review of the business it began late last year. ...
GSK's antibiotic gets FDA priority review for oral treatment of gonorrhoea
GSK's antibiotic gets FDA priority review for oral treatment of gonorrhoea
Aug 10, 2025
Aug 11 (Reuters) - British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority review of gepotidacin, an oral antibiotic to treat sexually transmitted uncomplicated gonorrhoea. GSK is counting on new infectious disease treatments, such as its recently launched respiratory syncytial virus vaccine, to help offset revenue losses from its top-selling...
GSK's antibiotic drug gepotidacin gets priority review by FDA
GSK's antibiotic drug gepotidacin gets priority review by FDA
Aug 10, 2025
Aug 11 (Reuters) - British drugmaker GSK said on Monday its supplemental new drug application for antibiotic drug gepotidacin has been accepted for priority review by the U.S. Food and Drug Administration for the oral treatment of uncomplicated urogenital gonorrhoea. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved